Breast cancer is one of the leading Cancers, which affects millions of women throughout the world. Even though many young women are increasingly getting breast cancer, it still remains most common ...

This narrative review summarizes existing literature and clinical trial data on metastasis-directed and locoregional therapy for oligometastatic and oligoprogressive metastatic breast cancer, ...

Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, but regimen-specific effects dominated the aggregate estimate.